Emerging leader in the CBD poised to seize opportunities to position and grow their product strategy. Shares of Golden Developing Solutions (OTCMKTS:DVLP) a new leader in CBD Products, continues to attract volume and attentions as shares rose an impressive 30% on Thursday.
The stock has been attracting attention and trading activity since they announced a Purchase Order for their CBD oils from a big distributor which provides Snack Foods and Accessories to the $28B Convenience Store and Gas Station market earlier in the week.
In a statement to shareholders, CEO Stavros Triant said that the Austin based firm was working through “a defining period of transition in 2018.” He stated that the 2nd half of the year would be a period of manifest commercial operations and initial revenue growth. This newly announced purchase order seems to point in that direction.
Hinting that there will be more news flow and announcements, Tirant also stated: “To help guide us through this critical transition and the establishment of new operational dimensions, we will be adding new talent and experience to our Board of Directors over the next several weeks, with details to follow in subsequent communications.”
Cannabis has shown encouraging signs as a treatment for various medical conditions and in the U.S. 29 states have passed laws permitting their citizens to use cannabis for medical and/or recreational purposes. DVLP’s cannabidiol (CBD), hemp oil and other health/wellness-related products seek to capitalize on this growth opportunity.
Also on the leaderboard during a busy trading day were Raven Industries (NASDAQ: RAVN) who saw their shares rise 14.13%. Seven Stars Cloud Group (NASDAQ: SSC) whose share value increased 14.37% and IZEA (NASDAQ: IZEA) saw shares jump 11.6%
Biocept Inc (NASDAQ: BIOC) rose 18.33% after it was announced that Highmark Health will study the clinical and economic impact of BIOC’s Target Selector liquid biopsy in patients with non-small cell lung cancer.
Sportsman’s Warehouse (NASDAQ: SPWH) rose 10.35% after the firm announced earnings. Their $203.3 million in sales beat Wall Street’s expectations of $202.1 million.